IL25120A - Pharmaceutical preparations containing fractions of avocado oil and / or soybean oil which cannot be sponged - Google Patents
Pharmaceutical preparations containing fractions of avocado oil and / or soybean oil which cannot be spongedInfo
- Publication number
- IL25120A IL25120A IL2512066A IL2512066A IL25120A IL 25120 A IL25120 A IL 25120A IL 2512066 A IL2512066 A IL 2512066A IL 2512066 A IL2512066 A IL 2512066A IL 25120 A IL25120 A IL 25120A
- Authority
- IL
- Israel
- Prior art keywords
- oil
- avocado
- soya
- treatment
- pharmaceutical preparations
- Prior art date
Links
- 235000012424 soybean oil Nutrition 0.000 title claims description 12
- 239000008163 avocado oil Substances 0.000 title claims description 11
- 235000021302 avocado oil Nutrition 0.000 title claims description 11
- 239000000825 pharmaceutical preparation Substances 0.000 title claims description 10
- 239000004480 active ingredient Substances 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 2
- 239000001828 Gelatine Substances 0.000 claims 1
- 229920000159 gelatin Polymers 0.000 claims 1
- 235000019322 gelatine Nutrition 0.000 claims 1
- 238000002360 preparation method Methods 0.000 description 9
- 230000001476 alcoholic effect Effects 0.000 description 6
- 244000025272 Persea americana Species 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 244000068988 Glycine max Species 0.000 description 4
- 235000010469 Glycine max Nutrition 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 235000008673 Persea americana Nutrition 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 230000002349 favourable effect Effects 0.000 description 3
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010034464 Periarthritis Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 201000001245 periodontitis Diseases 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 206010020601 Hyperchlorhydria Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- 235000012241 calcium silicate Nutrition 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 125000002345 steroid group Chemical group 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR5586A FR4194M (en)) | 1965-02-15 | 1965-02-15 | |
| FR5587A FR4195M (en)) | 1965-02-15 | 1965-02-15 | |
| FR5588A FR4174M (en)) | 1965-02-15 | 1965-02-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL25120A true IL25120A (en) | 1969-09-25 |
Family
ID=27241928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL2512066A IL25120A (en) | 1965-02-15 | 1966-02-04 | Pharmaceutical preparations containing fractions of avocado oil and / or soybean oil which cannot be sponged |
Country Status (5)
| Country | Link |
|---|---|
| BE (1) | BE676194A (en)) |
| FR (3) | FR4174M (en)) |
| GB (1) | GB1142804A (en)) |
| IL (1) | IL25120A (en)) |
| NL (1) | NL156926B (en)) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2041594A5 (en)) * | 1969-04-30 | 1971-01-29 | Expanscience | |
| GB1427253A (en) * | 1973-05-07 | 1976-03-10 | Kaneda T | Antilipemic composition containing unsaponifiable matter of soybean oil |
| FR2443835A1 (fr) * | 1979-10-09 | 1980-07-11 | Courtin Jacques | Creme pour les mains |
| SE8505569D0 (sv) * | 1985-11-25 | 1985-11-25 | Aco Laekemedel Ab | Enteralt preparat |
| FR2803598B1 (fr) * | 2000-01-12 | 2002-04-26 | Pharmascience Lab | Procede d'extraction des insaponifiables des huiles vegetales au moyen de chloro-1-butane, composition comprenant ces insaponifiables |
| AU2003241148A1 (en) * | 2003-04-10 | 2004-11-01 | Johnson & Johnson Limited | Cosmetic powder for treatment of acne and method of making the same |
| US8501663B2 (en) | 2009-06-26 | 2013-08-06 | Universidad Autonoma De Puebla | Process for obtaining an adsorbent from a waste material and use of the adsorbent |
-
1965
- 1965-02-15 FR FR5588A patent/FR4174M/fr not_active Expired
- 1965-02-15 FR FR5586A patent/FR4194M/fr not_active Expired
- 1965-02-15 FR FR5587A patent/FR4195M/fr not_active Expired
-
1966
- 1966-02-04 IL IL2512066A patent/IL25120A/en unknown
- 1966-02-08 BE BE676194D patent/BE676194A/xx not_active IP Right Cessation
- 1966-02-14 NL NL6601888.A patent/NL156926B/xx not_active IP Right Cessation
- 1966-02-15 GB GB6621/66A patent/GB1142804A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FR4195M (en)) | 1966-05-31 |
| GB1142804A (en) | 1969-02-12 |
| NL156926B (nl) | 1978-06-15 |
| FR4174M (en)) | 1966-05-23 |
| FR4194M (en)) | 1966-05-31 |
| NL6601888A (en)) | 1966-08-16 |
| BE676194A (en)) | 1966-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Maiga et al. | Antioxidant and 15-lipoxygenase inhibitory activities of the Malian medicinal plants Diospyros abyssinica (Hiern) F. White (Ebenaceae), Lannea velutina A. Rich (anacardiaceae) and Crossopteryx febrifuga (afzel) Benth.(Rubiaceae) | |
| US4842859A (en) | Pharmaceutical compositions for reducing hyperlipidemia and platelet-aggregation | |
| Bartelloni et al. | Combined therapy for chloroquine-resistant Plasmodium falciparum infection: Concurrent use of long-acting sulphormethoxine and pyrimethamine | |
| Muller et al. | European Drug Index: European Drug Registrations | |
| JPS62501360A (ja) | 製薬学的に活性な化合物を含有する病気治療剤 | |
| IL25120A (en) | Pharmaceutical preparations containing fractions of avocado oil and / or soybean oil which cannot be sponged | |
| Multhauf | Medical chemistry and" the Paracelsians" | |
| KR950007848A (ko) | (S)-(-)-α-에틸-2-옥소-1-피롤리딘아세트아미드를 사용한 불안치료방법 | |
| LONGCOPE et al. | The use of BAL (British anti-Lewisite) in the treatment of the injurious effects of arsenic, mercury and other metallic poisons | |
| KR870007118A (ko) | 광학적으로 순수한 화합물 및 그의 제조 방법 | |
| Sayre | A Manual of Organic Materia Medica and Pharmacognosy: An Introduction to the Study of the Vegetable Kingdom and the Vegetable and Animal Drugs (with Syllabus of Inorganic Remedial Agents) Comprising the Botanical and Physical Characteristics, Source, Constituents, Pharmacopoeial Preparations, Insects Injurious to Drugs, and Pharmacal Botany | |
| Lionel et al. | Levamisole in the treatment of ascariasis in children | |
| RU2012350C1 (ru) | Средство для снятия алкогольного опьянения | |
| FR3021224A1 (fr) | Phytomedicament pour le vih | |
| KR890004705A (ko) | 항바이러스성 제제 | |
| Huq | Comparative phytochemical evaluation and biological activity screening of Murdannia nudiflora and Tradescantia pallida | |
| US2910403A (en) | Anti hypertensive compositions comprising 2-methyl-5, 8-dimethoxychromone and acetamides | |
| Kabir et al. | Study of antidiarrheal and anthelmintic activity methanol extract of Commelina benghalensis leaves | |
| Shulgin | DOB | |
| JP2729340B2 (ja) | 痴呆症治療剤 | |
| JPH01246224A (ja) | 抗痴呆症剤 | |
| FR3080282A1 (fr) | Phytomedicament a activite antibacterienne contre l'ulcere gastroduodenal et la maladie de crohn | |
| EPSTEIN et al. | Cycloserine-isoniazid combination therapy in virgin cases of pulmonary tuberculosis | |
| Greenbaum et al. | The elimination of iodine after oral or intravenous administration of various iodine compounds in single massive doses | |
| YUE et al. | Toleration and absorption of sodium para-aminosalicylate and para-aminosalicylic acid (neopasalate): comparison with other forms of para-aminosalicylic acid |